• Cushman, Higgins, Stein, and Heil Recognized with UVM Faculty Awards
    May 17, 2023
    The University of Vermont (UVM) recently recognized Mary Cushman, M.D., M.Sc., Stephen Higgins, Ph.D., and Gary Stein, Ph.D., as University Distinguished Professors, and Sarah Heil, Ph.D., was named a 2023-24 University Scholar.
  • Looking at the Future of Cardiovascular Health through the Lens of Early-Career Investigators
    February 22, 2023
    The University of Vermont’s Larner College of Medicine features some of the world’s foremost cardiovascular researchers, experts in cardiovascular disease risk factors, thrombosis, atherosclerosis, stroke, and heart failure. the science shared by early-career investigators at the Cardiovascular Research Institute of Vermont’s fourth annual Viridis Montis Challenge, it was apparent that the institution’s reputation and legacy in the field of cardiovascular research will continue to have a global impact.
  • Cushman and Colleagues Find Social Disparities in Treatments and Outcomes for Pulmonary Embolism
    December 20, 2022
    Racial minorities and people with lower incomes or who are insured by Medicare or Medicaid are significantly less likely to receive the most advanced therapies and more likely to die after suffering a pulmonary embolism, according to a new analysis conducted by University of Vermont Professor of Medicine Mary Cushman, M.D., M.Sc., and colleagues.
  • 2022 Pilot Grant Award Recipients
    December 6, 2022
    These awards, supported wholly by funds from UVM entities, provide $200,000 over 2 years to fund meritorious research from early career faculty. We are very grateful to Deans from the Colleges of Medicine, Nursing & Health Sciences, Arts & Sciences, Engineering & Mathematical Sciences, and the Graduate College, as well as the Cardiovascular Research Institute of Vermont, for their support of this program. In addition, we would like to acknowledge matching fund support from the Departments of Molecular Physiology and Biophysics and Medicine.
  • Celebrating Larner’s Newest Facility: The Firestone Medical Research Building
    October 28, 2022
    On October 27, 2022, the UVM Larner College of Medicine held a grand opening and dedication of the newest addition to the medical campus: the Firestone Medical Research Building.
  • VCCBH Symposium Highlights Early Career Investigators, Innovative Multidisciplinary Research
    June 29, 2022
    More than 100 in-person and dozens of virtual participants attended the second annual Vermont Center for Cardiovascular and Brain Health (VCCBH) Symposium, held at the University of Vermont’s Davis Center June 2 to 3, 2022. The VCCBH, one of three National Institutes of Health Center of Biomedical Research Excellence-funded programs at UVM, is co-directed by Mary Cushman, M.D., M.Sc., professor and vice chair for emerging researchers in the Department of Medicine, and Mark Nelson, Ph.D., University Distinguished Professor and chair of the Department of Pharmacology.
  • UVM Hosts Second Symposium for Heart and Brain Health
    June 2, 2022
    The Vermont Center for Cardiovascular and Brain Health's annual symposium was featured in a news story on ABC22 and Fox44. on June 1.
    Read full story from
  • VCCBH Symposium Presenters Interviewed for Local ABC22/Fox44 Story
    June 2, 2022
    (JUNE 2, 2022) Assistant Professor of Rehabilitation and Movement Science Denise Peters, PT, D.P.T., Ph.D., was among those interviewed for a segment on the second annual VCCBH symposium that aired on Local ABC22/Fox44.
  • Johnson Awarded R01 NIH Grant
    April 7, 2022
    Congratulations to Abbie Chapman Johnson, Ph.D., for receiving her first R01 grant from the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) and the NIH National Institute on Aging.
  • Congratulations to Dr. Tim Plante
    March 21, 2022
    I’m pleased to tell you that our own Dr. Tim Plante received the Sandra Daugherty Award for Excellence in Hypertension or Epidemiology at the AHA Epidemiology/Lifestyle conference in Chicago yesterday! His abstract was presented as an oral presentation today and was based on his research funded by the CVRI Bloomfield Professorship, “Inflammatory cytokines and incident hypertension in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.”

Recent Stories and Publications Featuring VCCBH Members

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted July 10, 2024

Two Larner-affiliated researchers won their respective poster competitions at the Vermont Center for Cardiovascular and Brain Health symposium held June 6–7 at the University of Vermont’s Davis Center.

Movement of the endoplasmic reticulum is driven by multiple classes of vesicles marked by Rab-GTPases

Posted May 15, 2024

John Salogiannis, Ph.D., assistant professor of molecular physiology and biophysics, and members of his lab team—Allison (Morrissey) Langley, lab technician and Ph.D. candidate in cellular, molecular, and biomedical sciences; Sarah Abeling-Wang, lab research technician; and Erinn Wagner, UVM undergraduate biology major—have their first preprint*: “Movement of the endoplasmic reticulum is driven by multiple classes of vesicles marked by Rab-GTPases.” The team’s research is supported by an NIH Maximizing Investigators’ Research Award (MIRA or R35) for early-stage investigators.

The University of Vermont Center on Aging Newsletter

Posted May 2024

Katharine Cheung, M.D., Ph.D., M.Sc., interim director of the UVM Center on Aging, associate director for research, and assistant professor of medicine, and her mentee, medical student Susanna Schuler ’26, presented their research findings at the American Academy of Hospice and Palliative Medicine State of the Science meeting on March 23 in Phoenix, Arizona.

UVM Scientist Wins Chan Zuckerberg Initiative Grant to Tackle Neurodegenerative Diseases

Larner Scientist Seeks to Advance Neurodegeneration Research

February 22, 2024

Larner College of Medicine scientist Osama Harraz, Ph.D., M.Sc., and his colleague from the University of Maryland (UMD), Thomas Longden, Ph.D., are recipients of a prestigious Collaborative Pairs Pilot Project Award from the Chan Zuckerberg Initiative’s (CZI) Neurodegeneration Challenge Network (NCDN).